|
Market Closed -
Nasdaq
01:00:00 18/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.850 USD | -2.06% |
|
-19.03% | -43.67% |
| 11-05 | SCYNEXIS, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| 10-22 | SCYNEXIS, Inc. Completes Phase 1 Study Of Intravenous SCY-247 | CI |
ETFs positioned on SCYNEXIS, Inc.
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
| +6.29% | 0% | 32,130 M€ | ||
| +12.29% | 0% | 12,086 M€ | ||
| +7.43% | 0% | 692,025 M€ | ||
| +11.77% | 0% | 14,144 M€ | ||
| +5.54% | 0% | 4,204 M€ | ||
| +8.82% | 0% | 1,674 M€ | ||
| +8.41% | 0% | 7,793 M€ | ||
| +2.64% | 0% | 688 M€ | ||
| -6.86% | 0% | 59 M€ | ||
| +5.12% | 0% | 594 M€ | ||
| +7.70% | 0% | 19 M€ | ||
| -3.12% | 0% | 580 M€ | ||
| +4.43% | 0% | 26 M€ | ||
| +2.59% | 0% | 176 M€ | ||
| +5.11% | 0% | 727 M€ | ||
| +7.48% | 0% | 194 M€ | ||
| +0.00% | 0% | 18 M€ | ||
| +5.60% | -.--% | 513 M€ | ||
| +7.96% | -.--% | 156 M€ | ||
| +5.64% | -.--% | 146 M€ | ||
| +8.58% | -.--% | 62 M€ |
Employees
18
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SCYX Stock
- ETFs SCYNEXIS, Inc.
Select your edition
All financial news and data tailored to specific country editions
















